COVID-19 as a Risk Factor For Autoimmune Skin Disease

Lisa M Arkin¹, John S Barbieri^{2

3}, Edward W Cowen⁴

Affiliations

¹ Department of Dermatology, University of Wisconsin School of Medicine and Public Health, Madison.
² Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.
³ Associate Editor, JAMA Dermatology.
⁴ Dermatology Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland.

Lisa M Arkin et al. JAMA Dermatol. 2024.

. 2024 Dec 1;160(12):1269-1271.

doi: 10.1001/jamadermatol.2024.4222.

Lisa M Arkin¹, John S Barbieri^{2

3}, Edward W Cowen⁴

¹ Department of Dermatology, University of Wisconsin School of Medicine and Public Health, Madison.
² Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.
³ Associate Editor, JAMA Dermatology.
⁴ Dermatology Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland.

No abstract available

Comment in

Long-Term Risk of Autoimmune and Autoinflammatory Connective Tissue Disorders Following COVID-19.
Heo YW, Jeon JJ, Ha MC, Kim YH, Lee S. Heo YW, et al. JAMA Dermatol. 2024 Dec 1;160(12):1278-1287. doi: 10.1001/jamadermatol.2024.4233. JAMA Dermatol. 2024. PMID: 39504045 Free PMC article.
New Research Suggests Increased Risk of Some Autoimmune Disorders After COVID-19.
Anderer S. Anderer S. JAMA. 2025 Jan 14;333(2):111. doi: 10.1001/jama.2024.24894. JAMA. 2025. PMID: 39671215 No abstract available.